Patent · US Active

Methods for affecting body composition using amylin agonists

US8748375B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignees

Amylin Pharmaceuticals, LLC · US
AstraZeneca Pharmaceuticals LP · US

Inventors

Christine M. Mack · Ventura, US
Jonathan David Roth · San Diego, US

Key dates

Filing date	Mar 17, 2010
Grant date	Jun 10, 2014
Priority date	—
Expiry date	Mar 17, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.